血流边缘:扩大血液造血干细胞疗法的视野
Spencer D Shelton1, Vijay G Sankaran1
1Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Howard Hughes Medical Institute, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Trends in molecular medicine
|March 22, 2025
概括
使用造血干细胞移植 (HSCT) 的基因疗法显示出治疗血友病A的前景. 患者在经过F8lentiviral HSCT基因治疗后实现了持久的第八因子恢复和临床改善.
科学领域:
- 血液学 血液学 血液学
- 基因治疗 基因治疗
- 分子生物学分子生物学
背景情况:
- 自主造血干细胞移植 (HSCT) 正在越来越多地探索蛋白质缺乏症.
- 额外血造蛋白质缺乏症带来了独特的治疗挑战.
研究的目的:
- 为了评估F8 lentiviral HSCT基因治疗在患有血友病A.患者的疗效.
- 评估长期的VIII因子恢复和临床结果.
主要方法:
- 通过自主HSCT给药F8的lentiviral基因治疗.
- 监测治疗患者的VIII因子水平和临床状态.
主要成果:
- 在A型血友病患者中实现了持久的VIII因子恢复.
- 在基因疗法后,经过显著的临床改善.
结论:
- F8 lentiviral HSCT基因疗法为血友病A提供了可行的治疗方法.
- 这一进步可以扩大HSCT在遗传疾病中的应用.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Bone Marrow Sampling and Transplants
268
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
268
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Hematopoiesis
5.0K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.0K


